Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

809 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Influence of the IL17A locus in giant cell arteritis susceptibility.
Márquez A, Hernández-Rodríguez J, Cid MC, Solans R, Castañeda S, Fernández-Contreras ME, Ramentol M, Morado IC, Narváez J, Gómez-Vaquero C, Martínez-Taboada VM, Ortego-Centeno N, Sopeña B, Monfort J, García-Villanueva MJ, Caminal-Montero L, de Miguel E, Blanco R; Spanish GCA Consortium; Palm O, Molberg O, Latus J, Braun N, Moosig F, Witte T, Beretta L, Santaniello A, Pazzola G, Boiardi L, Salvarani C, González-Gay MA, Martín J. Márquez A, et al. Among authors: salvarani c. Ann Rheum Dis. 2014 Sep;73(9):1742-5. doi: 10.1136/annrheumdis-2014-205261. Epub 2014 Jun 11. Ann Rheum Dis. 2014. PMID: 24919468 Free article.
-463 G/A myeloperoxidase promoter polymorphism in giant cell arteritis.
Salvarani C, Casali B, Farnetti E, Pipitone N, Nicoli D, Macchioni PL, Cimino L, Bajocchi GL, Catanoso MG, Pattacini L, Ghinoi A, Restuccia G, Boiardi L. Salvarani C, et al. Ann Rheum Dis. 2008 Apr;67(4):485-8. doi: 10.1136/ard.2007.074666. Epub 2007 Aug 17. Ann Rheum Dis. 2008. PMID: 17704068
Long-term outcome of giant cell arteritis.
Pipitone N, Boiardi L, Bajocchi G, Salvarani C. Pipitone N, et al. Among authors: salvarani c. Clin Exp Rheumatol. 2006 Mar-Apr;24(2 Suppl 41):S65-70. Clin Exp Rheumatol. 2006. PMID: 16859599 Review.
Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.
Cid MC, Unizony SH, Blockmans D, Brouwer E, Dagna L, Dasgupta B, Hellmich B, Molloy E, Salvarani C, Trapnell BC, Warrington KJ, Wicks I, Samant M, Zhou T, Pupim L, Paolini JF; KPL-301-C001 Investigators. Cid MC, et al. Among authors: salvarani c. Ann Rheum Dis. 2022 May;81(5):653-661. doi: 10.1136/annrheumdis-2021-221865. Epub 2022 Mar 9. Ann Rheum Dis. 2022. PMID: 35264321 Free PMC article. Clinical Trial.
Toll-like receptor 4 (TLR4) gene polymorphisms in giant cell arteritis.
Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Macchioni P, Cimino L, Bajocchi GL, Catanoso MG, Pattacini L, Ghinoi A, Restuccia G, Salvarani C. Boiardi L, et al. Among authors: salvarani c. Clin Exp Rheumatol. 2009 Jan-Feb;27(1 Suppl 52):S40-4. Clin Exp Rheumatol. 2009. PMID: 19646345
809 results